NSEGeneral Updates30 Jun 2026 · 30 Jun 2026, 06:41 pm
General Updates
Jubilant Pharmova Limited · JUBLPHARMA
✦ AI SummaryLitigation
Jubilant Pharmova Limited has received a rectification order from the jurisdictional Assessing Officer in Noida for Assessment Year 2019-20, disallowing a claim of forward losses of Rs. 53.37 crores. The company is in the process of filing an appeal before the Appellate Authority (National Faceless Appeal Centre) against the impugned order.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Jubilant Pharmova Limited has informed the Exchange about General Updates
Attachments (1)
📄pdf
Download →
JUBLPHARMA_30062026184057_JBL_-_Stock_Exchange_Disclosure.pdf
View document text
June 30, 2026
BSE Limited National Stock Exchange of India Limited
Floor 25, P. J. Towers Exchange Plaza
Dalal Street, Fort Bandra Kurla Complex
Mumbai - 400 001 Bandra (E)
Mumbai - 400 051
Scrip Code: 530019 Symbol: JUBLPHARMA
Sub.: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (“Listing Regulations”)
Dear Sir,
Pursuant to Regulation 30 of the Listing Regulations read with Schedule III and the SEBI Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, we hereby inform that Jubilant
Biosys Limited (wholly owned subsidiary of Jubilant Pharmova Ltd.) has received a rectification order
dated June 29, 2026 from the jurisdictional Assessing Officer in Noida for Assessment Year 2019-20
(Financial Year 2018-19).
The information in the relevant format is enclosed as Annexure A.
The Company believes that the impugned tax adjustment has been made ignoring the facts and
contentions of the Company and provisions of law. The Company is in the process of taking the
necessary action to file an appeal before the Appellate Authority [National Faceless Appeal Centre
(NFAC)] against the impugned order. Post adjudication by Appellate authority, impugned adjustment
is likely to get deleted.
Date and time of occurrence of event is June 30, 2026, 12:20 pm (IST).
The above-mentioned document is being simultaneously posted on the Company's website at
www.jubilantpharmova.com.
We request you to take this on record.
Thanking you.
Yours faithfully,
For Jubilant Pharmova Limited
Naresh Kapoor
Company Secretary
Annexure A
Sr. Brief details of Name of the Court/tribunal/ Expected financial Quantum of
No. Litigation opposing party Agency where implications, if any, claims (in Rs.
litigation is due to compensation, crores)
filed penalty etc.
1 Rectification order DCIT, Noida Company is in Company is in the Disallowance
dated June 29, 2026 the process of process of filing an of claim of
amending assessment filing an appeal appeal before first brought
u/s 143(1) of the before National level Appellate forward losses
Income-tax Act, Faceless Appeal Authority (National of Rs. 53.37
1961, passed by the Centre (NFAC) Faceless Appeal crores
jurisdictional Centre - NFAC)
Assessing Officer in against the
Noida for Assessment rectification order and
Year 2019-20 expects to get relief
(Financial Year 2018- from the Appellate
19) disallowing the Authority and does not
claim of brought anticipate any material
forward losses of Rs. adverse financial
53.37 crores implication